We were proud to publish an article in the specialist magazine “Swiss Pharma”, issue 1/22. The topic of this issue was modern qualification with best practice examples.
You can find our article on page 50 of the magazine. You can find the link to the edition here.
Or read the article directly on our website:
Canexis Pharma has received an extended GMP manufacturing license (Part I) from Swissmedic for the production of bulk finished medicinal products. This means that Canexis is now
A day of knowledge and development: Our annual internal GMP training day 2024 To support our continuous efforts to ensure the highest quality standards
Canexis Pharma AG is expanding at its site in Schlattingen. With the acquisition of another 2 plots and around 2000m2
